InnovaVector s.r.l. is CDMO operator specialized in AAV vectors. InnovaVector has over 30 years history of providing Clients AAV vectors for preclinical purposes reliably of all major serotypes. Solving clients productivity problems is our normal assignment. Company is moving to extend this expertise to phase I/II clinical trials, when InnovaVector’s new state of the art GMP facility comes online in Q1 2023. Our brand new facility, highly experienced scientific team with extensive past GMP background and our problem solving commitment to work closely with clients every step of the way, have helped us to build an excellent reputation in the AAV gene therapy market. We are now seeking authorization under EMA for the production of gene therapy products for clinical supply for CDMO clients. Find out more about our services by visiting our webpage. Our mission is to provide solutions for AAV success in advanced medicines. InnovaVector is a lively and international working community with rapidly expanding career opportunities, that people aspire to work for. We are located in subtropical Campania-region in Pozzuoli (Naples) very close to Mediterranean sea shore and surrounded by ancient architectural recoveries.